Novavax expects FDA clearance for Covid vaccine as early as May, CEO says

Retrieved on: 2021-03-01 22:02:01

Tags for this article:

Click the tags to see associated articles and topics

Novavax expects FDA clearance for Covid vaccine as early as May, CEO says. View article details on hiswai:

Excerpt

The FDA could authorize Novavax's Covid-19 vaccine for emergency use as early as May, the company's CEO, Stanley Erck, told CNBC.

Article found on: www.cnbc.com